A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.
about
Integrated network analysis of transcriptomic and proteomic data in psoriasisDesign of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarateEmerging drugs for moderate-to-severe psoriasis.Diet and psoriasis: experimental data and clinical evidence.Identifying disease-specific genes based on their topological significance in protein networks.Expression of Angiogenic Factors in Psoriasis VulgarisThe vitamin D3 pathway in human skin and its role for regulation of biological processes.[Nutritional influences in psoriasis].Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cellsTh1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planusAutoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.Angiogenesis drives psoriasis pathogenesis.Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy.Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety.Aquaporins in the Skin.Erythrodermic psoriasis: current and future role of biologicals.Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling.Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life.Dramatic improvement of psoriatic erythroderma after acute hepatitis: analysis of cytokine synthesis capability in peripheral blood T cells.Expression of Th1 and Th2 Cytokine and Associated Transcription Factors in Peripheral Blood Mononuclear Cells and Correlation with Disease Severity.Xiaoyin recipe ( ) for psoriasis induces a Th1/Th2 balance drift toward Th2 in peripheral blood mononuclear cells of experimental autoimmune thyroiditis rats.Erythrodermic psoriasis: pathophysiology and current treatment perspectives.
P2860
Q24610642-5902CB73-78C0-4599-A760-F870128E92EBQ27021147-5A7016DD-275E-4359-889A-273447682029Q30984470-2045618D-3285-4DDF-A474-D06EBFA7817DQ31006990-F939E8F1-8791-4E0D-9E07-EFE3191C4BA0Q33421110-6437CC3A-3FBF-4685-B2F9-22330A30D268Q33666312-68E96AD7-560A-4DF5-8069-65C290D06734Q34560802-EE58BCF3-91AC-4B64-9BD2-CC910D2DE325Q34606688-04995541-9D00-4BCD-9445-5092D6153378Q35441339-A83CA5DD-DBC0-4994-B3F9-6602054AB352Q35741166-09956F67-E652-4B7E-9BBC-FFFB9787C90EQ36854682-6F9A47CA-D9F3-4BC8-8EBA-687593E3B15CQ37534974-69D2AAE0-3DF2-4A81-9482-6E23803316FAQ38305758-5C30B690-957F-4F5D-B57A-A94CED0F6B19Q38387687-2FD5F366-1111-4A61-8556-AC6AC927D214Q38930229-F3FFF5D5-B95F-44E1-A57F-61E39B1DFE29Q39031386-155B1968-4591-4A9C-BD00-4E4241B023E5Q42970191-B452111B-B0AC-4354-9E95-F98E59CCEEB2Q43645804-AEDDDEA5-5D1B-4F27-9690-35CA3BA1824EQ44541733-D42B2E16-8013-4498-AD2C-3A6FD6B5790EQ47135666-7FDB06E5-FC80-4B08-8852-F29799DBA43EQ54325409-DD83ADB5-DAD6-4BDD-A910-AB5A53E71CC0Q55020325-7FFE1309-4D9B-49B9-936A-887D815006F4
P2860
A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@ast
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@en
type
label
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@ast
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@en
prefLabel
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@ast
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@en
P2093
P1476
A molecule solves psoriasis? S ...... terleukin 4 and Th2 responses.
@en
P2093
Kamran Ghoreschi
Martin Röcken
Ulrich Mrowietz
P2888
P304
P356
10.1007/S00109-003-0460-9
P577
2003-07-18T00:00:00Z